1 / 1

Evaluation of DAAs with PEG-IFN–Ribavirin in Chronic Hepatitis C

A review of trials assessing the effectiveness of DAAs combined with PEG-IFN and ribavirin for chronic hepatitis C treatment. The study explores potential future therapies for this condition.

braima
Download Presentation

Evaluation of DAAs with PEG-IFN–Ribavirin in Chronic Hepatitis C

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 7 Trials evaluating DAAs with a PEG-IFN–ribavirin backbone Dabbouseh, N. M. & Jensen, D. M. (2013)Future therapies for chronic hepatitis C Nat. Rev. Gastroenterol. Hepatol.doi:10.1038/nrgastro.2013.17

More Related